Start an analysis for C
Citigroup Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $30.0bn | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Remaining authorization | $23.0bn | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $3.0bn | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 07-May-26 | $30.0bn | $23.0bn | n/a | Represents repurchases under the multiyear $30 billion common stock repurchase program that was previously approved by Citigroup's Board of Directors and announced on May 7, 2026.10-Q filed 05-Nov-26 |
Open-market repurchases
- Jan ’26
- Feb ’26
- Mar ’26
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 14,961,000 | $133.72 | $2.0bn | 10-Q filed 05-Nov-26 |
| 31-Aug-26 | 4,658,000 | $135.59 | $632m | 10-Q filed 05-Nov-26 |
| 31-Jul-26 | 2,791,000 | $131.80 | $368m | 10-Q filed 05-Nov-26 |
| 30-Jun-26 | 28,865,000 | $138.58 | $4.0bn | 10-Q filed 06-Aug-26 |